Scale -


  • Revenue is 473 Rs Cr; Annual Growth is 16 %; Continuous Growth over 3 years
  • PBT is 17.16 Rs Cr; Continuous Growth over 3 years; Annual Decline is -21 %
  • Quarterly Ebitda is 24.18 Rs Cr; Continuous Growth over 3 Quarters
  • PAT is 42.22 Rs Cr; Annual Decline is -15 %
  • Ebitda is 90.14 Rs Cr; Continuous Decline over 3 years

Profitability -


  • Quarterly Ebitda Margin is 19 %; Continuous Growth over 3 Quarters
  • PBDIT Margin is 19.07 %; Annual Decline is -15 %; Continuous Decline over 3 years
  • PAT Margin is 8.93 %; Annual Decline is -27 %

Return -


  • ROCE is 16.36 %; in Top Quartile; Annual Decline is -30 %; Continuous Decline over 3 years
  • ROA is 9.08 %; in Top Quartile; Annual Decline is -30 %; Continuous Decline over 3 years
  • Asset Turnover is 111 %; in Top Quartile; Continuous Decline over 3 years
  • ROE is 15.67 %; Annual Decline is -22 %; Continuous Decline over 3 years

Efficiency -


  • Current Ratio is 1.12; Continuous Growth over 3 years; in Bottom Quartile
  • Quick Ratio is 0.99; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 48.65; Continuous Growth over 3 years; 5 Year CAGR is 40 %

Solvancy -


  • Contingent Liabilities is 12.7 Rs Cr; Annual Decline is -35 %
  • Debt/Equity is 0.06; 5 Year CAGR is -44 %
  • Long term Debt is 7.16 Rs Cr; 5 Year CAGR is -44 %; Continuous Growth over 3 years
  • Total Debt is 16.11 Rs Cr; 5 Year CAGR is -36 %; Continuous Growth over 3 years

Quality -


  • Operating cashflow/ebitda is 90 %; Annual Growth is 23 %
  • Operating cashflow/PAT is 192 %; Annual Growth is 42 %
  • Current Tax/PAT is 30 %; Annual Growth is 23 %
  • Other Expenses/Total Expenses is 51 %; Continuous Growth over 3 years; in Top Quartile
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Change in Inventories/Total Expenses is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Compare with
Paras Healthcare Ltd. Dividend Payout History
PARAS HEALTHCARE LTD. Stock/Share price , NSE/BSE Forecast News and Live Quotes
Sonic Healthcare Limited (ASX:SHL): German Diagnostics and Digital Pathology Priorities
GPT Healthcare Limited Estimates – NSE:GPTHEALTH
Sonic Healthcare Limited (ASX:SHL): Operations, Earnings and Business Priorities
Ryman Healthcare Limited (ASX:RYM): Operations, Recent Results and Business Developments
GPT Healthcare Dividend 2026: ?1.50, Record Date 30 Jul & History
Sonic Healthcare Limited (ASX:SHL) Builds Digital Pathology Capability in Germany
Sonic Healthcare Limited (ASX: SHL): FY2026 Results Highlight European Integration and Diagnostic Growth
GPT Healthcare (GPTHEALTH.NS) Slips 1.26% to ?149.56, Testing Key Support Zone